EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases

D Augustijn iD, R Bonte, M C Hagemeijer iD, J Bierau iD, E H Jacobs, C J Klein-de Ronde, E van der Star, D Y van Haaften-Visser iD, N C Peltenburg-de Jong, C Debuy iD, M van Dijk iD, D Vos und 2 weitere

Journal of Inherited Metabolic Disease · 2026-11 · 49 (6)

DOI: 10.1002/jimd.70260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 09.11.2026. Verfasst von D Augustijn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Lysosomal and Metabolic Diseases, Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Metabolomics, Metabolic Diseases, Metabolism, Inborn Errors. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited metabolic diseases (IMD) require timely diagnosis since a considerable number of these disorders respond to early treatment. Traditional metabolic screening relies on multiple targeted assays guided by clinical symptoms, making it laborious and potentially increasing the risk of underdiagnosis. Untargeted metabolomics provides broader biochemical coverage, but evidence of its diagnostic performance is limited. In this metabolomics implementation study, we analysed 484 plasma samples submitted for routine metabolic screening using both targeted assays and metabolomics in parallel. The results of these analyses were independently interpreted by two laboratory specialists and results were compared. Overall, 85.5% concordance was achieved between the two approaches. The majority of discrepancies stem from aberrant biomarkers traditionally measured in urine observed in metabolomics but not in the targeted plasma analyses. Importantly, inconclusive results requiring follow up were equally observed among the two methods. Metabolomics screening resulted in the detection of one new and one tentative IMD, which were not detected by targeted tests. Collectively, these results support the application of untargeted metabolomics for IMD screening in clinical practice. In addition to our study results, we share our detailed protocol and workflow towards implementation of untargeted metabolomics in clinical practice to facilitate broader use of diagnostic metabolomics in the IMD community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsMetabolic DiseasesMetabolism, Inborn ErrorsHumansBiomarkersMass ScreeningFemaleMale

Stichwörter der Autor:innen

IMDdiagnosticsimplementationmetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Centre of Lysosomal and Metabolic Diseases, Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Department of Clinical Chemistry, Erasmus MC, Rotterdam, the Netherlands.
  • Centre of Lysosomal and Metabolic Diseases, Department of Paediatrics, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Centre of Lysosomal and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam University Medical Centre, Amsterdam, the Netherlands.

ORCID-Profile: D Augustijn, M C Hagemeijer, J Bierau, D Y van Haaften-Visser, C Debuy, M van Dijk, G J G Ruijter

Zitieren

APA

Augustijn, D., Bonte, R., Hagemeijer, M. C., Bierau, J., Jacobs, E. H., Klein-de Ronde, C. J., van der Star, E., van Haaften-Visser, D. Y., Peltenburg-de Jong, N. C., Debuy, C., van Dijk, M., Vos, D., Ruijter, G. J. G., & Goorden, S. M. I. (2026). Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases. Journal of Inherited Metabolic Disease, 49(6). https://doi.org/10.1002/jimd.70260

Vancouver

Augustijn D, Bonte R, Hagemeijer MC, Bierau J, Jacobs EH, Klein-de Ronde CJ, et al. Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases. Journal of Inherited Metabolic Disease. 2026;49(6). doi:10.1002/jimd.70260

BibTeX
@article{Augustijn2026,
  author = {Augustijn, D and Bonte, R and Hagemeijer, M C and Bierau, J and Jacobs, E H and Klein-de Ronde, C J and van der Star, E and van Haaften-Visser, D Y and Peltenburg-de Jong, N C and Debuy, C and van Dijk, M and Vos, D and Ruijter, G J G and Goorden, S M I},
  title = {Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {6},
  doi = {10.1002/jimd.70260}
}
Kostenlos starten →